UK markets closed
NIKKEI 225
38,236.07 -37.98 (-0.10%) HANG SENG
18,207.13 +444.10 (+2.50%) CRUDE OIL
78.95 -0.05 (-0.06%) GOLD FUTURES
2,311.60 +0.60 (+0.03%) DOW
38,225.66 +322.37 (+0.85%) Bitcoin GBP
47,320.93 +1,818.95 (+4.00%)
Allergy Therapeutics plc (AGYTF)
Other OTC - Other OTC Delayed price. Currency in USD
Add to watchlist
At close: 10:37AM EDT
Currency in USD
Valuation measures4
| Market cap (intra-day) | 171.15M |
| Enterprise value | 166.56M |
| Trailing P/E | N/A |
| Forward P/E | N/A |
| PEG ratio (5-yr expected) | N/A |
| Price/sales (ttm) | 0.51 |
| Price/book (mrq) | 2.87 |
| Enterprise value/revenue | 3.13 |
| Enterprise value/EBITDA | -4.27 |
Trading information
Stock price history
| Beta (5Y monthly) | 1.34 |
| 52-week change 3 | -88.57% |
| S&P500 52-week change 3 | 23.57% |
| 52-week high 3 | 0.1750 |
| 52-week low 3 | 0.0100 |
| 50-day moving average 3 | 0.0180 |
| 200-day moving average 3 | 0.0615 |
Share statistics
| Avg vol (3-month) 3 | 204 |
| Avg vol (10-day) 3 | N/A |
| Shares outstanding 5 | 4.77B |
| Implied shares outstanding 6 | 8.68B |
| Float 8 | 239.13M |
| % held by insiders 1 | 93.21% |
| % held by institutions 1 | 0.12% |
| Shares short 4 | N/A |
| Short ratio 4 | N/A |
| Short % of float 4 | N/A |
| Short % of shares outstanding 4 | N/A |
| Shares short (prior month ) 4 | N/A |
Dividends & splits
| Forward annual dividend rate 4 | N/A |
| Forward annual dividend yield 4 | N/A |
| Trailing annual dividend rate 3 | 0.00 |
| Trailing annual dividend yield 3 | 0.00% |
| 5-year average dividend yield 4 | N/A |
| Payout ratio 4 | 0.00% |
| Dividend date 3 | N/A |
| Ex-dividend date 4 | N/A |
| Last split factor 2 | N/A |
| Last split date 3 | N/A |
Financial highlights
Currency in GBP.Fiscal year
| Fiscal year ends | 30 Jun 2023 |
| Most-recent quarter (mrq) | 31 Dec 2023 |
Profitability
| Profit margin | -94.29% |
| Operating margin (ttm) | -34.15% |
Management effectiveness
| Return on assets (ttm) | -34.76% |
| Return on equity (ttm) | -155.90% |
Income statement
| Revenue (ttm) | 53.26M |
| Revenue per share (ttm) | 0.03 |
| Quarterly revenue growth (yoy) | -15.90% |
| Gross profit (ttm) | N/A |
| EBITDA | -37M |
| Net income avi to common (ttm) | -50.22M |
| Diluted EPS (ttm) | -0.0700 |
| Quarterly earnings growth (yoy) | N/A |
Balance sheet
| Total cash (mrq) | 13.52M |
| Total cash per share (mrq) | 0 |
| Total debt (mrq) | 9.85M |
| Total debt/equity (mrq) | 37.22% |
| Current ratio (mrq) | 1.40 |
| Book value per share (mrq) | 0.01 |
Cash flow statement
| Operating cash flow (ttm) | -32.2M |
| Levered free cash flow (ttm) | -17.3M |
© 2024 Yahoo. All rights reserved.